Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediGuard was a U.S. healthcare information and patient engagement company operated by iGuard that provided consumers with medication safety alerts, drug interaction warnings, recall notifications, and personalized medication risk information. The company built a large online patient community organized by medications and conditions, which also supported clinical research and trial recruitment activities. Founded in 2007 by Hugo Stephenson, the business was originally launched as iGuard.org and later branded as MediGuard. It became part of Quintiles Transnational and was used within Quintiles' digital patient and clinical research efforts. The business appears to have been commercialized as a service/platform rather than as a therapeutic developer, so it does not have a drug pipeline in the biotech sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medigard.